1.
Nurse Pract
; 47(3): 18-28, 2022 03 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35171863
RESUMO
ABSTRACT: Transgender and gender-nonbinary patients may present to primary care providers seeking gender-affirming hormone therapy. Patients who meet criteria for diagnosis of gender incongruence may start or continue hormone therapy after providing informed consent. Prescribing and monitoring of masculinizing and feminizing hormone therapy can be managed in primary care settings.